<DOC>
	<DOCNO>NCT01985347</DOCNO>
	<brief_summary>The prevalence anxiety depression OSA population COPD general population North West Adelaide . ( principal hypothesis ) . CPAP therapy OSA population produce positive effect anxiety depression scale . The Investigators intend study prevalence anxiety depression patient sleep disorder comparison patient COPD subsequently , ass whether CPAP role control anxiety depression depress anxious patient sleep apnoea . This two phase study , first phase ; investigator ass prevalence anxiety depression , population sleep disorder check whether different prevalence COPD population . The prevalence depression Sleep Disorder population also compare Adelaide North Western general population , report The North West Adelaide Health Study . According epidemiological survey , conduct 2008 2010 , prevalence depression Adelaide North Western general population 20 % .During second phase study investigator evaluate effect CPAP anxiety depression score depress anxious patient sleep apnoea compare pre post CPAP anxiety depression status . The Hospital Anxiety Depression ( HAD ) scale use assess Anxiety Depression , well-documented tool assess symptom anxiety depression patient somatic disease .</brief_summary>
	<brief_title>The SAD Study - SLEEP , ANXIETY &amp; DEPRESSION Study A Prospective Cohort Study</brief_title>
	<detailed_description>AIM ( S ) / OBJECTIVE OF STUDY 1 . To compare prevalence anxiety depression patient sleep disorder ( OSA ) , COPD general population North West Adelaide . 2 . To study effect CPAP depression anxiety patient sleep apnoea also anxiety depression . STUDY DESIGN/ SETTING/LOCATION/POPULATION This multicenter Prospective Cohort study run Lyell McEwin Hospital ( LMH ) The Queen Elizabeth Hospital ( TQEH ) , among patient attend Respiratory Sleep Outpatient Clinics Lyell McEwin Hospital ( LMH ) The Queen Elizabeth Hospital ( TQEH ) . These site teach tertiary hospital . STUDY OUTCOMES 1 . Primary Outcome To establish prevalence anxiety depression patient sleep disorder compare prevalence differs prevalence COPD general population . 2 . Secondary Outcome To evaluate whether treatment CPAP improve anxiety depression symptom ( HAD scale ) 3 12 month OSA patient anxiety depression .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Patients attend Respiratory Sleep Outpatient Clinics LMH TQEH OSA COPD Aged 18 year Unwilling unable give inform write consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>